India, Dec. 11 -- The company aims to capture emerging opportunities in India and globally for plant-based Vitamin D3, sustainable biocatalysis, and advanced nutritional ingredients

Fermenta Biotech announced that its Board of Directors has approved a capital investment of Rs 110 crore for expanding capacities at its existing Dahej, Gujarat facility.

The comprehensive investment programme, spanning multiple high-value segments, leverages Fermenta's proprietary technologies and decades of manufacturing excellence to capture emerging opportunities in India and globally for plant-based Vitamin D3, sustainable biocatalysis, and advanced nutritional ingredients.

The investments will be implemented in phases across FY26 and FY27, using an op...